$LTRN
Lantern Pharma Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Dallas, TX
LTRN chart
What traders are saying about $LTRN
Latest postsLantern Pharma Inc. news
- Lantern Pharma Publishes Phase 1a Glioblastoma Data, Advances LP-184 Combination Therapy Toward Phase 1b/2a Trial
citybuzz - ·
- Lantern Pharma publishes phase 1a data for LP-184 in glioblastoma By Investing.com
Investing.com India ·
- Lantern Pharma Announces Peer-Reviewed Publication of Phase 1a LP-184 Data in Recurrent Glioblastoma, Supporting a Phase 1b/2a Combination Trial with Spironolactone
Yahoo Finance ·
- Lantern Pharma Q3 2026 Earnings Date and Estimates
MarketBeat ·
- Lantern Pharma Inc expected to post a loss of 35 cents a share - Earnings Preview
TradingView ·
- What Could Go Wrong With Recursion Pharmaceuticals Stock?
trefis.com ·
- Lantern Pharma to Present at the ThinkEquity Conference in NYC on October 15th, 2026
Yahoo Finance ·
- Lantern Pharma secures Taiwan clearances for Phase II NSCLC study
clinicaltrialsarena.com ·
- Lantern Pharma Receives Taiwan Approvals to Open Next Stage of Phase 2 HARMONIC™ Trial of LP-300 in Never-Smoker, EGFR-Mutant NSCLC
Yahoo Finance ·
- Lantern Pharma Inc. Announces Closing of up to $8 Million Registered Direct Offering
Yahoo Finance ·
- Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering
Yahoo Finance ·
- New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global
Yahoo Finance ·
Lantern Pharma Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$17.1M | -$20.8M | -$16.0M | -$14.3M |
| Diluted EPS | $-1.57 | $-1.93 | $-1.47 | $-1.31 |
| Total assets (year end) | $11.0M | $25.6M | $43.6M | $58.8M |
| Cash and equivalents (year end) | $4.4M | $7.5M | $21.9M | $37.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Lantern Pharma Inc.
- Ticker
- LTRN (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Dallas, TX
- Incorporated in
- TX
- Fiscal year end
- December 31
- SEC CIK
- 1763950
- Former names
- Lantern Pharma
Frequently asked questions
What exchange is Lantern Pharma Inc. listed on?
Lantern Pharma Inc. trades on the Nasdaq under the ticker symbol LTRN.
What industry is Lantern Pharma Inc. in?
Lantern Pharma Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Lantern Pharma Inc. headquartered?
Lantern Pharma Inc.'s business address on file with the SEC is in Dallas, TX.
When does Lantern Pharma Inc.'s fiscal year end?
Lantern Pharma Inc.'s fiscal year ends on December 31.